Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · IEX Real-Time Price · USD
50.91
+0.61 (1.21%)
At close: May 1, 2024, 4:00 PM
51.60
+0.69 (1.36%)
After-hours: May 1, 2024, 6:11 PM EDT
Apogee Therapeutics Market Cap
Apogee Therapeutics has a market cap or net worth of $2.87 billion as of May 1, 2024.
Market Cap
2.87B
Enterprise Value
2.48B
1-Year Change
n/a
Ranking
Category
Stock Price
$50.91
Market Cap Chart
Since the IPO on July 14, 2023, Apogee Therapeutics's market cap has increased from $808.89M to $2.87B, an increase of 255.04%. That is a compound annual growth rate of 390.01%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 30, 2024 | 2.55B | 2.66% |
Apr 29, 2024 | 2.48B | 3.97% |
Apr 26, 2024 | 2.39B | 2.77% |
Apr 25, 2024 | 2.32B | -1.46% |
Apr 24, 2024 | 2.36B | -6.49% |
Apr 23, 2024 | 2.52B | 2.32% |
Apr 22, 2024 | 2.46B | 3.69% |
Apr 19, 2024 | 2.38B | -2.98% |
Apr 18, 2024 | 2.45B | -6.12% |
Apr 17, 2024 | 2.61B | 1.66% |
Apr 16, 2024 | 2.57B | -4.54% |
Apr 15, 2024 | 2.69B | -3.60% |
Apr 12, 2024 | 2.79B | -5.15% |
Apr 11, 2024 | 2.94B | 9.99% |
Apr 10, 2024 | 2.67B | -6.39% |
Apr 9, 2024 | 2.86B | 3.21% |
Apr 8, 2024 | 2.77B | -3.85% |
Apr 5, 2024 | 2.88B | -3.71% |
Apr 4, 2024 | 2.99B | -1.66% |
Apr 3, 2024 | 3.04B | 0.16% |
Apr 2, 2024 | 3.03B | -7.92% |
Apr 1, 2024 | 3.30B | -2.11% |
Mar 28, 2024 | 3.37B | -2.44% |
Mar 27, 2024 | 3.45B | 3.62% |
Mar 26, 2024 | 3.33B | 1.12% |
View and export this data all the way back to 2023.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Immunocore Holdings | 2.96B |
Azenta | 2.94B |
Olink Holding AB (publ) | 2.87B |
Arrowhead Pharmaceuticals | 2.85B |
Janux Therapeutics | 2.83B |
GoodRx Holdings | 2.81B |
ACADIA Pharmaceuticals | 2.80B |
Summit Therapeutics | 2.79B |